title: Alternation of estrogen receptor and progesterone receptor expression in primary breast cancer patients treated with neoadjuvant chemotherapy.
authors.forename: Dai
authors.initials: D
authors.lastname: Kitagawa
authors.forename: Shigehira
authors.initials: S
authors.lastname: Saji
authors.forename: Shin-Ichiro
authors.initials: S
authors.lastname: Horiguchi
authors.forename: Yu
authors.initials: Y
authors.lastname: Satoh
authors.forename: Kazumi
authors.initials: K
authors.lastname: Horiguchi
authors.forename: Masakazu
authors.initials: M
authors.lastname: Toi
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Funata
authors.forename: Katsumasa
authors.initials: K
authors.lastname: Kuroi
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone